financetom
Business
financetom
/
Business
/
Meta Platforms Unusual Options Activity
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Meta Platforms Unusual Options Activity
Aug 20, 2025 1:26 PM

Deep-pocketed investors have adopted a bullish approach towards Meta Platforms ( META ) , and it's something market players shouldn't ignore. Our tracking of public options records at Benzinga unveiled this significant move today. The identity of these investors remains unknown, but such a substantial move in META usually suggests something big is about to happen.

We gleaned this information from our observations today when Benzinga's options scanner highlighted 251 extraordinary options activities for Meta Platforms ( META ). This level of activity is out of the ordinary.

The general mood among these heavyweight investors is divided, with 40% leaning bullish and 32% bearish. Among these notable options, 113 are puts, totaling $7,512,519, and 138 are calls, amounting to $12,719,926.

Projected Price Targets

Based on the trading activity, it appears that the significant investors are aiming for a price territory stretching from $5.0 to $900.0 for Meta Platforms ( META ) over the recent three months.

Analyzing Volume & Open Interest

Examining the volume and open interest provides crucial insights into stock research. This information is key in gauging liquidity and interest levels for Meta Platforms's ( META ) options at certain strike prices. Below, we present a snapshot of the trends in volume and open interest for calls and puts across Meta Platforms's ( META ) significant trades, within a strike price range of $5.0 to $900.0, over the past month.

Meta Platforms Option Activity Analysis: Last 30 Days

Significant Options Trades Detected:

Symbol PUT/CALL Trade Type Sentiment Exp. Date Ask Bid Price Strike Price Total Trade Price Open Interest Volume
META PUT TRADE BEARISH 09/19/25 $29.1 $28.8 $29.0 $760.00 $522.0K 1.6K 333
META CALL TRADE NEUTRAL 12/17/27 $739.05 $738.6 $738.82 $5.00 $443.2K 5.6K 311
META PUT SWEEP NEUTRAL 01/15/27 $123.55 $122.9 $122.9 $790.00 $307.2K 126 77
META CALL TRADE BULLISH 09/05/25 $24.4 $24.2 $24.4 $737.50 $234.2K 10 185
META PUT TRADE BULLISH 08/29/25 $14.75 $14.6 $14.6 $750.00 $146.0K 1.0K 1.7K

About Meta Platforms

Meta is the largest social media company in the world, boasting close to 4 billion monthly active users worldwide. The firm's "Family of Apps," its core business, consists of Facebook, Instagram, Messenger, and WhatsApp. End users can leverage these applications for a variety of different purposes, from keeping in touch with friends to following celebrities and running digital businesses for free. Meta packages customer data, gleaned from its application ecosystem and sells ads to digital advertisers. While the firm has been investing heavily in its Reality Labs business, it remains a very small part of Meta's overall sales.

After a thorough review of the options trading surrounding Meta Platforms ( META ), we move to examine the company in more detail. This includes an assessment of its current market status and performance.

Present Market Standing of Meta Platforms

With a volume of 9,938,568, the price of META is down -0.43% at $748.28.

RSI indicators hint that the underlying stock may be approaching overbought.

Next earnings are expected to be released in 70 days.

Professional Analyst Ratings for Meta Platforms

5 market experts have recently issued ratings for this stock, with a consensus target price of $880.2.

Turn $1000 into $1270 in just 20 days?

20-year pro options trader reveals his one-line chart technique that shows when to buy and sell. Copy his trades, which have had averaged a 27% profit every 20 days. Click here for access.

* An analyst from Cantor Fitzgerald has revised its rating downward to Overweight, adjusting the price target to $920.

* An analyst from Stifel persists with their Buy rating on Meta Platforms ( META ), maintaining a target price of $900.

* An analyst from Wells Fargo persists with their Overweight rating on Meta Platforms ( META ), maintaining a target price of $811.

* An analyst from B of A Securities persists with their Buy rating on Meta Platforms ( META ), maintaining a target price of $900.

* An analyst from Oppenheimer persists with their Outperform rating on Meta Platforms ( META ), maintaining a target price of $870.

Options trading presents higher risks and potential rewards. Astute traders manage these risks by continually educating themselves, adapting their strategies, monitoring multiple indicators, and keeping a close eye on market movements. Stay informed about the latest Meta Platforms ( META ) options trades with real-time alerts from Benzinga Pro.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Nike bosses plan 'biggest' Olympics spend as marketing ramps up
Nike bosses plan 'biggest' Olympics spend as marketing ramps up
Apr 12, 2024
PARIS, April 12 (Reuters) - Nike ( NKE ) is spending more on this Olympics than any previous Games, top executives said on Friday, as the U.S. sportswear brand embarks on a marketing push it hopes will revive flagging sales and help compete with upstart rivals. Sportswear makers are looking to reignite demand on the back of Paris 2024, which...
Adaptimmune Therapeutics Says Unit Gets Termination Notice for Strategic Collaboration With Genentech
Adaptimmune Therapeutics Says Unit Gets Termination Notice for Strategic Collaboration With Genentech
Apr 12, 2024
09:08 AM EDT, 04/12/2024 (MT Newswires) -- Adaptimmune Therapeutics plc ( ADAP ) said Friday that its Adaptimmune Ltd. unit has received a notice of termination of the strategic collaboration and license agreement with Genentech and F. Hoffman-La Roche. Under the agreement, which was signed in 2021, Genentech and Adaptimmune worked together to develop two types of allogeneic T-cell therapies,...
Apple Loses Appeal to Dismiss UK Lawsuit Over App Store Fees
Apple Loses Appeal to Dismiss UK Lawsuit Over App Store Fees
Apr 12, 2024
09:06 AM EDT, 04/12/2024 (MT Newswires) -- Apple's ( AAPL ) appeal to throw out a UK mass lawsuit, which accuses the iPhone maker of charging third-party developers excessive and unfair commissions, was rejected, according to the Competition Appeal Tribunal ruling published Friday. In its unanimous decision, the Tribunal said the case has a realistic prospect of establishing that the...
Centenario Details Phase 2 Exploration Program At Eden Project
Centenario Details Phase 2 Exploration Program At Eden Project
Apr 12, 2024
09:08 AM EDT, 04/12/2024 (MT Newswires) -- Centenario Gold Corp. (CTG.V), at 52 week lows, on Friday outlined the details of the second phase of its exploration program at the Eden property near Prime Mining Corp.'s ( PRMNF ) Los Reyes project in Mexico. Centenario said its geological team is analyzing the recent drill data and reinterpreting the geological information...
Copyright 2023-2026 - www.financetom.com All Rights Reserved